FMC.com
|
Investor Relations
|
Careers
|
News
|
Corporate Responsibility
About Us
Events
What's New
Avicel for solid dose forms
Avicel for suspensions
Ac-Di-Sol
Aquacoat
Protanal and Protacid
Viscarin, Gelcarin, and SeaSpen
Innovation
Innovative Soft Capsules
Immediate Release
Tablets
Liquids and Suspensions
Sustained Release
Multiparticulates
Matrix Tablets
Topical Preparations
Enteric Drug Delivery
Organoleptic Enhancements
Dental Applications
Anti-Reflux
Nutraceuticals
Request a sample
Location Finder
U.S., Canada, Puerto Rico
Asia Pacific, China, Japan, Australia
Mexico, Central America
Europe
South America
Africa, Middle East, South West Asia
Register
Matrix Tablets
Hydrophilic polymers may be included in tablets in order to form a viscous, gelling layer which retards water penetration and acts as a barrier to drug release. Drug release is accomplished by diffusion through and erosion of this barrier. Zero-order release profiles can be achieved by selection of appropriate polymers and other fillers/ binders. The use of FMC’s carrageenan and alginate in this application provide:
Suppression of acid burst seen with basic drugs
24-hour release rates
Release profiles that can be tailored by combining gelling and viscous grades
Recommended Products:
Protanal® LF 240 D, LF 120 M, LF 200 M
Viscarin® GP-209, GP-379
Sustained Release Applications
Multiparticulates
Matrix Tablets
Useful Application Documents
Link
Brochure - Alginate
Bulletin - Controlled Release Technology
Brochure - Carrageenan
Bulletin - Alginate in Controlled Release
Go